PUBLISHER: The Business Research Company | PRODUCT CODE: 1947026
PUBLISHER: The Business Research Company | PRODUCT CODE: 1947026
A pulmonary artery catheter (PAC) is a specialized catheter used to measure pressures within the heart and pulmonary arteries. It supplies essential information about cardiovascular function, particularly in critically ill patients, and is commonly used in intensive care to monitor cardiac output, pulmonary pressures, and other hemodynamic measurements.
The primary products in pulmonary artery catheters include four-lumen, five-lumen, six-lumen artery catheters, and others. A four-lumen artery catheter is a medical device featuring four separate channels to support functions such as hemodynamic monitoring, medication administration, and blood sampling. These devices are used in intensive care units (ICUs), non-intensive care settings, and other clinical environments, including hospitals, long-term care facilities, and others.
Tariffs are impacting the pulmonary artery catheter market by raising costs of imported catheter components and pressure sensors, impacting hospitals and ICUs in North America and Asia-Pacific. High-end multi-lumen catheters face greater pricing pressure. On the positive side, tariffs are accelerating local production, supplier diversification, and cost-efficient catheter innovations.
The pulmonary artery catheter market research report is one of a series of new reports from The Business Research Company that provides pulmonary artery catheter market statistics, including pulmonary artery catheter industry global market size, regional shares, competitors with a pulmonary artery catheter market share, detailed pulmonary artery catheter market segments, market trends and opportunities, and any further data you may need to thrive in the pulmonary artery catheter industry. This pulmonary artery catheter market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The pulmonary artery catheter market size has grown steadily in recent years. It will grow from $1.26 billion in 2025 to $1.32 billion in 2026 at a compound annual growth rate (CAGR) of 4.8%. The growth in the historic period can be attributed to growth in critical care admissions, adoption in cardiac surgeries, advancement in ICU monitoring, clinician familiarity with PACs, increased cardiovascular disease burden.
The pulmonary artery catheter market size is expected to see steady growth in the next few years. It will grow to $1.58 billion in 2030 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to demand for advanced hemodynamic data, growth in complex ICU cases, technological improvements in catheter design, expansion of critical care infrastructure, emerging economies healthcare growth. Major trends in the forecast period include shift toward minimally invasive hemodynamic monitoring, increased use in high-risk cardiac procedures, rising preference for disposable catheters, focus on accuracy and safety enhancements, decline in routine use in low-risk patients.
The increasing incidence of lung diseases is increasingly supporting the expansion of the pulmonary artery catheter market going forward. Lung diseases affect the respiratory system and impair the lungs' ability to exchange oxygen and carbon dioxide effectively. The rising incidence of lung diseases is strongly linked to increasing air pollution, as prolonged exposure to harmful pollutants damages lung tissue and contributes to chronic respiratory conditions. Pulmonary artery catheters are used to assess heart and lung function by measuring pressures within the pulmonary artery, aiding in the diagnosis and management of complex cardiopulmonary conditions. For example, in May 2025, according to the Centers for Disease Control and Prevention, a US-based government agency, the age-adjusted prevalence of diagnosed chronic obstructive pulmonary disease among adults aged 18 years and older was 3.8%, with higher prevalence observed among women than men. As a result, the growing incidence of lung diseases is strengthening demand for pulmonary artery catheters.
Leading companies operating in the pulmonary artery catheter market are developing innovative products, such as endovascular catheters, to improve the accuracy of hemodynamic monitoring, enhance patient safety, and support minimally invasive assessment of cardiac function and pulmonary pressures. An endovascular catheter is a specialized medical device used to access and monitor the pulmonary artery. For example, in January 2024, Thrombolex Inc., a US-based medical device company, launched the BASHIR.035 and BASHIR S-B endovascular catheters for the treatment of acute pulmonary embolism. These catheters feature an expandable infusion basket that enables targeted thrombolysis by delivering thrombolytic agents directly into the clot, facilitating rapid restoration of blood flow, reducing procedure time, and improving patient safety.
In September 2024, Becton, Dickinson and Company, a US-based medical device company, acquired Edwards Lifesciences Inc. for an undisclosed amount. This acquisition is designed to strengthen BD's critical care product portfolio and reinforce its position in advanced patient monitoring solutions. Edwards Lifesciences Inc. is a US-based medical device company specializing in heart valve technologies, hemodynamic monitoring, and critical care solutions.
Major companies operating in the pulmonary artery catheter market are Cardinal Health Corp, Medtronic Inc, Becton Dickinson And Company, Philips Healthcare Corp, Boston Scientific Corporation, Medline Industries Inc, B Braun Melsungen AG, Terumo Corporation, Edwards Lifesciences Corporation, Nipro Corporation, Smiths Medical Group, Teleflex Incorporated, Merit Medical Systems Inc, Vygon SA, ICU Medical Inc, Argon Medical Devices Inc, Biosensors International Group Ltd, Getinge AB, Osypka Medical GmbH, Pulsion Medical Systems SE, Cook Medical
North America was the largest region in the pulmonary artery catheter market in 2025. The regions covered in the pulmonary artery catheter market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the pulmonary artery catheter market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The pulmonary artery catheter market consists of sales of swan-ganz catheters, heparin-bonded catheters, multi-lumen catheters, temperature-sensing catheters, and pressure monitoring catheters. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Pulmonary Artery Catheter Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses pulmonary artery catheter market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for pulmonary artery catheter ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The pulmonary artery catheter market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.